ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical total assets
Total assets on the balance sheet at the end of each period.
ENvue Medical's total assets was $38.41M at Jun 30, 2026. For fiscal 2025 it was $41.12M, up 1033.2% from the year before. Over ten years it grew 35.4% a year on average. The highest annual figure on record is $41.12M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.12M | +1033.2% |
| FY2024 | Dec 31, 2024 | $3.63M | -45.6% |
| FY2023 | Dec 31, 2023 | $6.67M | +13.5% |
| FY2022 | Dec 31, 2022 | $5.88M | -31.8% |
| FY2021 | Dec 31, 2021 | $8.62M | +4.8% |
| FY2020 | Dec 31, 2020 | $8.23M | +304.2% |
| FY2019 | Dec 31, 2019 | $2.04M | +28.9% |
| FY2018 | Dec 31, 2018 | $1.58M | -67.5% |
| FY2017 | Dec 31, 2017 | $4.87M | +884.8% |
| FY2016 | Dec 31, 2016 | $494.00K | -75.1% |
| FY2015 | Dec 31, 2015 | $1.98M | +174.3% |
| FY2014 | Dec 31, 2014 | $723.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $38.41M | -25.4% |
| Q1 FY2026 | Mar 31, 2026 | $39.87M | -9.6% |
| Q4 FY2025 | Dec 31, 2025 | $41.12M | +1033.2% |
| Q3 FY2025 | Sep 30, 2025 | $54.38M | +1061.5% |
| Q2 FY2025 | Jun 30, 2025 | $51.48M | +803.8% |
| Q1 FY2025 | Mar 31, 2025 | $44.11M | +607.4% |
| Q4 FY2024 | Dec 31, 2024 | $3.63M | -45.6% |
| Q3 FY2024 | Sep 30, 2024 | $4.68M | -36.4% |
| Q2 FY2024 | Jun 30, 2024 | $5.70M | +48.7% |
| Q1 FY2024 | Mar 31, 2024 | $6.24M | +29.6% |
| Q4 FY2023 | Dec 31, 2023 | $6.67M | +13.5% |
| Q3 FY2023 | Sep 30, 2023 | $7.36M | +41.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.83M | -41.4% |
| Q1 FY2023 | Mar 31, 2023 | $4.81M | -37.2% |
| Q4 FY2022 | Dec 31, 2022 | $5.88M | -31.8% |
| Q3 FY2022 | Sep 30, 2022 | $5.21M | -46.1% |
| Q2 FY2022 | Jun 30, 2022 | $6.54M | -4.2% |
| Q1 FY2022 | Mar 31, 2022 | $7.66M | -10.9% |
| Q4 FY2021 | Dec 31, 2021 | $8.62M | +4.8% |
| Q3 FY2021 | Sep 30, 2021 | $9.67M | +135.6% |
| Q2 FY2021 | Jun 30, 2021 | $6.83M | +577.1% |
| Q1 FY2021 | Mar 31, 2021 | $8.60M | +667.4% |
| Q4 FY2020 | Dec 31, 2020 | $8.23M | +304.2% |
| Q3 FY2020 | Sep 30, 2020 | $4.10M | +33.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.01M | -67.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.12M | +37.2% |
| Q4 FY2019 | Dec 31, 2019 | $2.04M | +28.9% |
| Q3 FY2019 | Sep 30, 2019 | $3.07M | +26.6% |
| Q2 FY2019 | Jun 30, 2019 | $3.11M | -2.1% |
| Q1 FY2019 | Mar 31, 2019 | $817.00K | -79.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.58M | -67.5% |
| Q3 FY2018 | Sep 30, 2018 | $2.43M | +199.8% |
| Q2 FY2018 | Jun 30, 2018 | $3.17M | +319.2% |
| Q1 FY2018 | Mar 31, 2018 | $3.98M | +791.3% |
| Q4 FY2017 | Dec 31, 2017 | $4.87M | +884.8% |
| Q3 FY2017 | Sep 30, 2017 | $809.00K | -34.6% |
| Q2 FY2017 | Jun 30, 2017 | $757.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $446.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $494.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $1.24M | – |
See a number that looks wrong?